[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Travis, W.D., Brambilla, E., Nicholson, A.G., et al. (2015) The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. Journal of Thoracic Oncology, 10, 1243-1260. https://doi.org/10.1097/JTO.0000000000000630
|
[3]
|
de Koning, H.J., van der Aalst, C.M., de Jong, P.A., et al. (2020) Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. The New England Journal of Medicine, 382, 503-513.
https://doi.org/10.1056/NEJMoa1911793
|
[4]
|
Huang, H., Wang, T., Hu, B., et al. (2015) Visceral Pleural Invasion Remains a Size-Independent Prognostic Factor in Stage I Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery, 99, 1130-1139.
https://doi.org/10.1016/j.athoracsur.2014.11.052
|
[5]
|
Liu, Q.X., Deng, X.F., Zhou, D., et al. (2016) Visceral Pleural Invasion Impacts the Prognosis of Non-Small Cell Lung Cancer: A Meta-Analysis. European Journal of Surgical Oncology, 42, 1707-1713.
https://doi.org/10.1016/j.ejso.2016.03.012
|
[6]
|
王鑫, 支修益. 国际肺癌研究协会(IASLC)第八版肺癌TNM分期解读[J]. 中华胸部外科电子杂志, 2016, 3(2): 70-76.
|
[7]
|
Travis, W.D., Brambilla, E., Rami-Porta, R., et al. (2008) Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Clas-sification for Lung Cancer. Journal of Thoracic Oncology, 3, 1384-1390. https://doi.org/10.1097/JTO.0b013e31818e0d9f
|
[8]
|
吴怀申, 黄怡良. 肺癌侵犯胸壁和脏层胸膜的术前诊断[J]. 日本医学介绍, 1986(9): 407.
|
[9]
|
史赛敏, 许蟠熊. 周围型肺癌侵犯胸膜和胸壁的超声诊断[J]. 临床超声医学杂志, 2000(1): 43-44.
|
[10]
|
Glazer, H.S., Duncan-Meyer, J., Aronberg, D.J., et al. (1985) Pleural and Chest Wall Invasion in Bronchogenic Carcinoma: CT Evaluation. Radiology, 157, 191-194. https://doi.org/10.1148/radiology.157.1.4034965
|
[11]
|
Ebara, K., Takashima, S., Jiang, B., et al. (2015) Pleural Invasion by Peripheral Lung Cancer: Prediction with Three- Dimensional CT. Academic Radiology, 22, 310-319. https://doi.org/10.1016/j.acra.2014.10.002
|
[12]
|
Onoda, H., Higashi, M., Murakami, T., et al. (2021) Correlation between Pleural Tags on CT and Visceral Pleural Invasion of Peripheral Lung Cancer That Does Not Appear Touching the Pleural Surface. European Radiology, 31, 9022-9029. https://doi.org/10.1007/s00330-021-07869-y
|
[13]
|
Hsu, J.S., Han, I.T., Tsai, T.H., et al. (2016) Pleural Tags on CT Scans to Predict Visceral Pleural Invasion of Non-Small Cell Lung Cancer That Does Not about the Pleura. Radiology, 279, 590-596.
https://doi.org/10.1148/radiol.2015151120
|
[14]
|
胸膜凹陷征形成的病理基础[J]. 中华结核和呼吸杂志, 1988, 11(3): 188.
|
[15]
|
冯耀. 非小细胞肺癌脏层胸膜侵犯预测方法的研究现状[J]. 中国癌症防治杂志, 2016, 8(2): 129-132.
|
[16]
|
范丽, 刘士远. 磁共振成像在肺癌诊断和鉴别诊断中的应用和研究现状[J]. 当代医学, 2009, 15(8): 124-131.
|
[17]
|
Akata, S. (2008) Evaluation of Chest Wall Invasion by Lung Cancer Using Respiratory Dynamic MRI. Journal of Medical Imaging and Radiation Oncology, 52, 36-39. https://doi.org/10.1111/j.1440-1673.2007.01908.x
|
[18]
|
雷光, 曾亮, 陈雪, 等. 弹力纤维染色在恶性肿瘤中的研究进展[J]. 临床与实验病理学杂志, 2016, 32(9): 1037-1040.
|
[19]
|
周建云, 沈蓉, 代魁, 等. 弹性纤维染色在评估肺癌胸膜侵犯中的应用价值[J]. 中国组织化学与细胞化学杂志, 2020, 29(2): 171-174.
|
[20]
|
赵兰香, 余科科, 邵晋晨, 等. 弹力纤维染色在评估肺癌胸膜侵犯中的意义[J]. 临床与实验病理学杂志, 2014, 30(1): 22-24.
|
[21]
|
Deng, H.Y., Li, G., Luo, J., et al. (2018) Novel Biologic Factors Correlated to Visceral Pleural Invasion in Early-Stage Non-Small Cell Lung Cancer Less than 3 cm. Journal of Thoracic Disease, 10, 2357-2364.
https://doi.org/10.21037/jtd.2018.03.185
|
[22]
|
Zhang, H., Lu, C., Lu, Y., et al. (2016) The Predictive and Prog-nostic Values of Factors Associated with Visceral Pleural Involvement in Resected Lung Adenocarcinomas. OncoTargets and Therapy, 9, 2337-2348.
https://doi.org/10.2147/OTT.S100965
|
[23]
|
Qi, L.P., Li, X.T., Yang, Y., et al. (2016) Multivariate Analysis of Pleural Invasion of Peripheral Non-Small Cell Lung Cancer-Based Computed Tomography Features. Journal of Com-puter Assisted Tomography, 40, 757-762.
https://doi.org/10.1097/RCT.0000000000000439
|
[24]
|
Kudo, Y., Saji, H., Shimada, Y., et al. (2012) Impact of Visceral Pleural Invasion on the Survival of Patients with Non-Small Cell Lung Cancer. Lung Cancer, 78, 153-160. https://doi.org/10.1016/j.lungcan.2012.08.004
|
[25]
|
Shimizu, K., Yoshida, J., Nagai, K., et al. (2004) Visceral Pleural Invasion Classification in Non-Small Cell Lung Cancer: A Proposal on the Basis of Outcome Assessment. The Journal of Thoracic and Cardiovascular Surgery, 127, 1574-1578. https://doi.org/10.1016/j.jtcvs.2003.11.017
|
[26]
|
Imai, K., Minamiya, Y., Saito, H., et al. (2013) Detection of Pleural Lymph Flow Using Indocyanine Green Fluorescence Imaging in Non-Small Cell Lung Cancer Surgery: A Preliminary Study. Surgery Today, 43, 249-254.
https://doi.org/10.1007/s00595-012-0237-2
|
[27]
|
Yu, Y., Huang, R., Wang, P., et al. (2020) Sublobectomy versus Lobectomy for Long-Term Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer with a Tumor Size =2 cm Accompanied by Visceral Pleural Invasion: A SEER Population-Based Study. Journal of Thoracic Disease, 12, 592-604. https://doi.org/10.21037/jtd.2019.12.121
|
[28]
|
Shi, J., Yang, Y., Zhao, Y., et al. (2019) EGFR Mutations Are Significantly Associated with Visceral Pleural Invasion Development in Non-Small-Cell Lung Cancer Patients. Cancer Management and Research, 11, 1945-1957.
https://doi.org/10.2147/CMAR.S195747
|
[29]
|
Le, H., Wang, X., Zha, Y., et al. (2017) Peripheral Lung Adenocar-cinomas Harboring Epithelial Growth Factor Receptor Mutations with microRNA-135b Overexpression Are More Likely to Invade Visceral Pleura. Oncology Letters, 14, 7931-7940. https://doi.org/10.3892/ol.2017.7195
|
[30]
|
Brewer III, L.A., Bai, A.F., Little, J.N. and Rabago y Pardo, G. (1958) Carcinoma of the Lung: Practical Classification for Early Diagnosis and Surgical Treatment. Journal of the American Medical Association, 166, 1149-1155.
https://doi.org/10.1001/jama.1958.02990100037007
|
[31]
|
Jiang, L., Liang, W., Shen, J., et al. (2015) The Impact of Visceral Pleural Invasion in Node-Negative Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Chest, 148, 903-911. https://doi.org/10.1378/chest.14-2765
|
[32]
|
Luo, H., Qiao, L., Liang, N., et al. (2015) Risk Factors for Recurrence in Patients with Resected N1 Non-Small Cell Lung Cancer—A Systematic Review and Me-ta-Analysis. Journal of BUON, 20, 791-799.
|
[33]
|
Hung, J.J., Jeng, W.J., Hsu, W.H., et al. (2012) Prognostic Signifi-cance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-Small Cell Lung Cancer. Chest, 142, 141-150.
https://doi.org/10.1378/chest.11-2552
|
[34]
|
Luo, H. (2015) Risk Factors for Recurrence in Patients with Resected N1 Non-Small Cell Lung Cancer—A Systematic Review and Meta-Analysis. Journal of BUON: Official Journal of the Balkan Union of Oncology, 20, 791-799.
|
[35]
|
Scott, W.J., Howington, J., Feigenberg, S., et al. (2007) Treatment of Non-Small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest, 132, 234S-242S.
https://doi.org/10.1378/chest.07-1378
|
[36]
|
Mountain, C.F. (1998) Reflections on the Revisions in the International System for Staging Lung Cancer. Chest, 113, 1728-1729. https://doi.org/10.1378/chest.113.6.1729
|
[37]
|
林一丹, 蒋耀光, 王如文, 等. 手术治疗96例I期NSCLC远期疗效分析[J]. 中国肺癌杂志, 2001, 4(6): 431-434.
|
[38]
|
Ettinger, D.S., Wood, D.E., Aggarwal, C., et al. (2019) NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020. Journal of the National Comprehensive Cancer Network, 17, 1464-1472.
https://doi.org/10.6004/jnccn.2019.0059
|
[39]
|
Ettinger, D.S., Wood, D.E., Aisner, D.L., et al. (2021) NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. Journal of the National Comprehensive Cancer Network, 19, 254-266.
https://doi.org/10.6004/jnccn.2021.0013
|
[40]
|
Donington, J., Ferguson, M., Mazzone, P., et al. (2012) American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High-Risk Patients with Stage I Non-Small Cell Lung Cancer. Chest, 142, 1620-1635. https://doi.org/10.1378/chest.12-0790
|
[41]
|
Strauss, G.M., Herndon, J.E., Maddaus, M.A., et al. (2008) Adjuvant Paclitaxel plus Carboplatin Compared with Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. Journal of Clinical Oncology, 26, 5043-5051. https://doi.org/10.1200/JCO.2008.16.4855
|
[42]
|
Pignon, J.P., Tribodet, H., Scagliotti, G.V., et al. (2008) Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group. Journal of Clinical Oncology, 26, 3552-3559.
https://doi.org/10.1200/JCO.2007.13.9030
|
[43]
|
Arriagada, R., Bergman, B., Dunant, A., et al. (2004) Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 350, 351-360.
https://doi.org/10.1056/NEJMoa031644
|
[44]
|
Wu, Y.L., Tsuboi, M., He, J., et al. (2020) Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 383, 1711-1723. https://doi.org/10.1056/NEJMoa2027071
|
[45]
|
Winton, T., Livingston, R., Johnson, D., et al. (2005) Vinorelbine plus Cisplatin vs. Observation in Resected Non- Small-Cell Lung Cancer. The New England Journal of Medicine, 352, 2589-2597.
https://doi.org/10.1056/NEJMoa043623
|
[46]
|
Park, S.Y., Lee, J.G., Kim, J., et al. (2013) Efficacy of Plati-num-Based Adjuvant Chemotherapy in T2aN0 Stage IB Non-Small Cell Lung Cancer. Journal of Cardiothoracic Sur-gery, 8, 151. https://doi.org/10.1186/1749-8090-8-151
|